Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update2018 · 2,483 citations
2. 2Preoperative Profiling of Symptomatic Breast Cancer by Diagnostic Core Biopsy2005 · 71 citations
3. 3Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour2011 · 75 citations
4. 4Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma2001 · 70 citations
5. 5Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer2022 · 17 citations